Risk of target organ damage in patients with arterial hypertension and various numbers of metabolic syndrome components

Abstract


The metabolic syndrome is one of most socially significant and strategic problems of clinical medicine. It is known that metabolic syndrome promotes earlier and more expressed target organ damage in patients with arterial hypertension. However, correlation of the number of metabolic syndrome components with target organ damage, selection of metabolic syndrome components, influencing expressiveness on target organ damage, are studied insufficiently. In this study it is determined that with the elevating number of the metabolic syndrome components, the frequency and expressiveness of heart, kidney and vessel damage, accompanied by the increased risk of development of cardiovascular complications, increase in patients with the maximum number of the metabolic syndrome components. Moreover, it is revealed that the relative risk of simultaneous damage of heart, kidneys and vessels in patients with arterial hypertension and metabolic syndrome, apart from high blood pressure and abdominal obesity is associated with the increase of fasting glucose level.

Full Text

Restricted Access

About the authors

Yu V Zhernakova

Email: juli001@mail.ru

G Kh Sharipova

I E Chazova

Email: c34h@yandex.ru

References

  1. Simmons R.K, Alberti K.G, Gale E.A et al. The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia 2010; 53: 600-5.
  2. Mule G, Nardi E, Cottone S et al. Influence of metabolic syndrome on hypertension - related target organ damage. J Intern Med 2005; 257: 503-13.
  3. Cuspidi C, Meani S, Fusi V et al. Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome: the Evaluation of Target Organ Damage in Hypertension study. J Hypertens 2005; 23: 875-82.
  4. Kavamoto R, Tomita H, Oka Y et al. Metabolic syndrome amplifies the LDL-cholesterol associated increases in carotid atherosclerosis. Intern med 2005; 44: 1232-8.
  5. Cuspidi C, Meani S, Fusi V et al. Ambulatory blood pressure, target organ damage and left atrial size in never - treated essential hypertensive individuals. J Hypertens 2005; 23: 1589-95.
  6. Cuspidi C, Meani S, Valerio C et al. Age and target organ damage in essential hypertension: role of the metabolic syndrome. Am J Hypertens 2007; 20 (3): 296-303.
  7. Cuspidi C, Valerio C, Giudici V et al. Metabolic syndrome and multiple organ damage in essential hypertension. Blood Pressure 2008; 17: 195-203.
  8. Eguchi K, Schwartz J.E, Roman M.J et al. Metabolic syndrome less strongly associated with target organ damage than syndrome components in a healthy, working population. J Clin Hypertens (Greenwich) 2007; 9 (5): 337-44.
  9. Шарипова Г.М. Особенности поражения органов - мишеней у больных артериальной гипертонией в зависимости от наличия и отсутствия метаболического синдрома. Дис. д - ра мед. наук. М., 2009.
  10. Navarro J, Redón J, Cea-Calvo L et al. Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERICHTA study. Blood Press 2007; 16 (1): 20-7.
  11. Саидова М.А., Сергакова Л.М., Атауллаханова Д.М. и др. Современные эхокардиографические подходы к оценке гипертрофии миокарда и структурного состояния левого желудочка у больных артериальной гипертонией. Методическое пособие для врачей. М., 2007.
  12. Recommendations for Chamber Quantification: A Report from the American Society of Еchocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with European Association of Echocardiography. J Am Soc Echocardiogr 2005; 18: 1446-47.
  13. Stein J, Korcarz C.E, Hurst R.T et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by Society for vascular Medicine. J Am Soc Echocardiogr 2008; 21 (2): 93-111.
  14. Mancia G, Bombelli M, Corrao G et al. Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: dailylife blood pressure, cardiac damage, and prognosis. Hypertension 2007; 49: 40-7.
  15. Cuspidi C, Meani S, Valerio C et al. Ambulatory blood pressure, target organ damage and left atrial size innever - treated essential hypertensive individuals. J Hypertens 2005; 23: 1589-95.
  16. Leoncini G, Ratto E, Viazzi F et al. Metabolic syndrome is associated with early signs of organ damage in non - diabetic, hypertensive patients. J Intern Med 2005; 257: 454-60.
  17. Azevedo A, Bettencourt P, Almeida P.B et al. Increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities - cross - sectional study of the general population. MC Cardiovascular Disorders 2007; 7: 17.
  18. Mule G, Nardi E, Cottone S et al. Influenceof metabolic syndrome on hypertension - related target organ damage. J Intern Med 2005; 257: 503-13.
  19. Kawamoto R, Tomita H, Oka Y et al. Metabolic syndrome amplifies the LDL-cholesterol associated increases in carotid atherosclerosis.Intern Med 2005; 44: 1232-8.
  20. Ferrara L.A, Cardoni O, Mancini M, Zanchetti A. Metabolic syndrome and left ventricular hypertrophy in a general population. Results from the Gubbio Study. J Hum Hypertens 2007; 21 (10): 795-801.
  21. Redon J, Rovira E, Miralles A et al. Factorsrelated to the occurrence of microalbuminuria during antihypertensivetreatment in essential hypertension. Hypertension 2002; 39: 794-8.
  22. Segura J, Campo C, Roldan C et al. Hypertensive renal damage in metabolic syndrome is associated with glucose metabolism disturbances. J Am Soc Nephrol 2004; 1: 37-42.

Statistics

Views

Abstract - 14

PDF (Russian) - 8

Cited-By


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies